Baker Bros. Advisors’s First Tracks Biotherapeutics TRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16.8M Buy
+472,932
New +$18.5M 0.08% 52

Other funds holding TRAX

Baker Bros. Advisors's TRAX Position: Q3 2026 in Review

Baker Bros. Advisors opened a new position in First Tracks Biotherapeutics (TRAX) in Q3 2026: 472,932 shares worth $16.8M. The stake represents 0.08% of the portfolio and ranks #52 among its holdings.

182 funds tracked by Wall St. Rank hold TRAX as of Q3 2026.

  • Baker Bros. Advisors held 472,932 shares of First Tracks Biotherapeutics worth $16.8M as of Q3 2026.
  • First Tracks Biotherapeutics was a new Baker Bros. Advisors position in Q3 2026.
  • First Tracks Biotherapeutics made up 0.08% of Baker Bros. Advisors's portfolio in Q3 2026, its #52 holding.
  • 182 funds tracked by Wall St. Rank held First Tracks Biotherapeutics as of Q3 2026.

Based on Baker Bros. Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.